TrialAmerican journal of respiratory and critical care medicine2026

Tezepelumab in real-world US patients with severe asthma across phenotypes and underrepresented populations: the phase 4 PASSAGE study.

Njira L Lugogo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.